The γ-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl Ester Reduces Aβ Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice
Thomas A. Lanz(Kalamazoo College), Kalpana Merchant(Pfizer (United States)), Shinji Yamazaki, Lisa C. Adams(TUM Klinikum), Carol S. Himes, Giovanni Pallante, Ben Amore
Cited by 147
Related Papers
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
|The Lancet|2025|801
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
SenNet recommendations for detecting senescent cells in different tissues
|Nature Reviews Molecular Cell Biology|2024|330